Building a medtech brand?
We run PR and public affairs for companies in this market: from category launches and funding announcements to NHS procurement and regulatory communications.
SureScreen Diagnostics
Lateral-flow diagnostics manufacturer
Diagnostics & imaging
Derby-based, family-run manufacturer of lateral-flow and rapid diagnostic test kits, an NHS supplier since 2010 that produced 20 million UK-manufactured rapid COVID-19 tests for the UK government.
The read
SureScreen Diagnostics manufactures lateral-flow and rapid diagnostic test kits, including drug and alcohol tests, infectious-disease tests such as COVID-19, flu and Strep A, and health-screening products, supplying the NHS since 2010 and producing 20 million UK-manufactured rapid COVID-19 tests under a UK government contract.
A family-run business, it won two King's Awards for Enterprise in 2023, for Innovation and International Trade, reflecting both its UK manufacturing base and export reach into the EU, Australia, Central America and South East Asia.
The Bridgehead view
SureScreen's dual King's Awards in the same year, for innovation and export, is a rare double worth leading a story with, particularly for UK manufacturing and reshoring narratives around diagnostics supply.
Work with us
Working across the healthcare sector?
We advise NHS-facing organisations, providers and health systems on reputation, policy engagement and communications that understand the sector.
Related platforms
Others in the sector map
Self-test IVD manufacturer
BioSure
Essex-based manufacturer of CE-marked self-test IVDs, best known for producing the world's first CE-marked HIV self-test, sold through UK pharmacies and the NHS.
ReadBreath biopsy diagnostics
Owlstone Medical
Cambridge diagnostics company building breath-based tests, its Breath Biopsy platform, to detect cancer and other diseases from volatile organic compounds on a patient's breath.
ReadCardiology AI (echocardiography)
Ultromics
Oxford spinout building AI software that reads standard echocardiograms to flag hidden heart failure and cardiac amyloidosis, without any extra scanning equipment.
ReadThe firm that knows medtech
We map this sector because
we represent it.
Whether you build medical technology or run the health systems that buy it, we know the market, the media and the regulatory landscape it operates in. Thirty minutes with a partner tells you if we can help.
